Cargando…
Primary hyperparathyroidism as first manifestation in multiple endocrine neoplasia type 2A: an international multicenter study
OBJECTIVE: Multiple endocrine neoplasia type 2A (MEN 2A) is a rare syndrome caused by RET germline mutations and has been associated with primary hyperparathyroidism (PHPT) in up to 30% of cases. Recommendations on RET screening in patients with apparently sporadic PHPT are unclear. We aimed to esti...
Autores principales: | Larsen, Louise Vølund, Mirebeau-Prunier, Delphine, Imai, Tsuneo, Alvarez-Escola, Cristina, Hasse-Lazar, Kornelia, Censi, Simona, Castroneves, Luciana A, Sakurai, Akihiro, Kihara, Minoru, Horiuchi, Kiyomi, Barbu, Véronique Dorine, Borson-Chazot, Francoise, Gimenez-Roqueplo, Anne-Paule, Pigny, Pascal, Pinson, Stephane, Wohllk, Nelson, Eng, Charis, Aydogan, Berna Imge, Saranath, Dhananjaya, Dvorakova, Sarka, Castinetti, Frederic, Patocs, Attila, Bergant, Damijan, Links, Thera P, Peczkowska, Mariola, Hoff, Ana O, Mian, Caterina, Dwight, Trisha, Jarzab, Barbara, Neumann, Hartmut P H, Robledo, Mercedes, Uchino, Shinya, Barlier, Anne, Godballe, Christian, Mathiesen, Jes Sloth |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Bioscientifica Ltd
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7354718/ https://www.ncbi.nlm.nih.gov/pubmed/32375120 http://dx.doi.org/10.1530/EC-20-0163 |
Ejemplares similares
-
International initiative for a curated SDHB variant database improving the diagnosis of hereditary paraganglioma and pheochromocytoma
por: Ben Aim, Laurene, et al.
Publicado: (2022) -
Cluster-like headache: literature review
por: Giraud, Pierric, et al.
Publicado: (2002) -
Crude annual incidence rate of medullary thyroid cancer and RET mutation frequency
por: Milićević, Sara, et al.
Publicado: (2021) -
Fatigue and Wear Performance of Autoclave-Processed and Vacuum-Infused Carbon Fibre Reinforced Polymer Gears
por: Bergant, Zoran, et al.
Publicado: (2023) -
Letter to the Editor From Zandee and Links: “Metastatic Differentiated Thyroid Cancer Survival Is Unaffected by Mode of Preparation for (131)I Administration”
por: Zandee, Wouter T, et al.
Publicado: (2023)